Furthermore, Tks5 was shown to be required for ECM degradation in vitro (Stylli et al., 2009) as well as tumor growth and metastasis in vivo (Blouw et al., 2015; Blouw et al., 2008). Here, SH3PXD2A is linked to neoplasm.